NextCell Pharma is an innovative Biotech growing out of the need for Advanced Therapy Medicinal Products for Autoimmune Disease and Transplantation. Cellaviva, the first Swedish family saving stem cell bank, with its expertise in umbilical cord stem cells and Diamyd Medical with its interests and investments within autoimmune diseases made a natural partnership for creating NextCell Pharma. Clinical trials testing NextCell Pharma’s first product, ProTrans,has started in Novermber 2018.
#nextcellpharma #cellaviva

Biotechnology

Clinical Trials

Health Care

Therapeutics

NextCell Pharma AB

NextCell Pharma AB's headquarters in Huddinge, Sweden

Description

People (5)

Jobs (0)

Other offices